$ZENA — ZenaTech just received Irish Aviation Authority

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
37
$ZENA — ZenaTech just received Irish Aviation Authority approval and the regulatory strategy behind it is smarter than most people realize

Yesterday's news from ZenaTech got a lot less attention than it deserves. Let me break down why the Irish Aviation Authority (IAA) authorization matters beyond the headline.

What was announced (September 10, 2026):

ZenaTech's ZenaDrone subsidiary received SORA (Specific Operations Risk Assessment) approval from the Irish Aviation Authority — granted under European Union Aviation Safety Agency (EASA) guidelines — at its EMEA DaaS headquarters located near Dublin, Ireland.

The authorization specifically covers large-scale targeted aerial application of fertilizer, lime, bio stimulants, and other non-plant protection products on Irish farmland, as well as granular spreading at scale.

Why the EASA framework is the key detail:

Here's what makes this more interesting than a standard regulatory approval. The CEO explicitly called out the strategic significance of EASA:

"EASA's framework is used across the European Union, as this approval provides a replicable template to apply market by market rather than starting fresh."

This is not just an Ireland story. This is a pan-European market entry strategy disguised as a single-country approval. By clearing the SORA bar under EASA guidelines once, ZenaTech now has a documented, repeatable regulatory pathway it can use to expand across all EU member states — 27 countries — without having to rebuild the compliance case from the ground up in each one.

For a DaaS company whose entire model depends on recurring, subscription-based revenue across multiple geographies, this is a foundational piece of infrastructure.

The market problem they're solving is real:

Ireland's Environmental Protection Agency reported in 2026 that nitrogen concentrations in Irish rivers rose 10% year-over-year, with excess fertilizer runoff cited as a leading cause. Drone-based precision application directly addresses this — applying nutrients with pinpoint accuracy rather than blanket spreading, reducing runoff, soil compaction, and personnel exposure.

Fertilizer costs in Europe have been historically elevated since 2022. Any technology that measurably reduces input waste while also addressing environmental compliance risk is going to get attention from farmers and regulators alike.

The DaaS model and why it matters for revenue:

The authorization allows ZenaDrone to operate complex, autonomous aerial missions at scale — without requiring customers to navigate aviation safety regulation, pilot certification, hardware costs, or maintenance directly. Customers pay for the service. ZenaTech handles the regulatory compliance, the drones, and the operators.

This is exactly the asset-light, recurring-revenue model investors should want to see. Farmers don't want to own drones. They want their fields treated. ZenaTech shows up, does the work, bills monthly or per-acre, and moves to the next field.

How this fits into the bigger $ZENA picture:

For context on where this company is right now heading into its 8-event global investor and defense roadshow:

28 DaaS acquisitions closed — operating across North America, Europe, Middle East, Asia & Australia

Q1 2026 revenue up 640% YoY

Named 2026 Drone Technology of the Year — AgTech Breakthrough Awards

Interceptor P-1 counter-UAS platform — flight testing underway in Mesa, Arizona

IQ Octo precision agriculture drone prototype completed — field testing commencing

5 acoustic wildfire suppression patents filed

IQ Square public safety drone — testing commenced

Blue UAS / NDAA certification advancing for direct U.S. DoD procurement

AUSA Annual Meeting — Washington DC, October 12-14 — prearranged meetings with U.S. defense and government decision-makers confirmed

100% Section 232 tariffs on foreign drones via Presidential Proclamation = significant competitive moat for a domestically manufactured platform

Listed on NASDAQ, Frankfurt Stock Exchange (FSE), and Mexico's BMV

The bear case — be realistic:

This is a small cap with a complex, multi-vertical strategy — execution risk is real and significant

Many of the DaaS acquisitions are small businesses that still need to be integrated and scaled

The Irish authorization covers nutrients and bio stimulants — it does NOT cover crop protection products (pesticides/herbicides), which require a separate, more stringent authorization process

Revenue growth has been impressive but the company is still pre-profitability at the corporate level

Stock volatility has been significant in 2026

Bottom line:

The IAA authorization is meaningful not because Ireland is a huge market on its own, but because it hands ZenaTech a replicable EU regulatory template at a moment when they have the EMEA infrastructure, DaaS operational model, and investor roadshow calendar to act on it aggressively. Watch the European roadshow — Berlin, Munich, Frankfurt, London — September 28 through October 2.

Full PR here: https://finance.yahoo.com/technology/articles...00167.html

ZenaTech Inc. (ZENA) Stock Research Links

ZENA Board Company Profile Buy Rating Time & Sales News Filings Financials
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.

1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.

4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

A Comprehensive Look at Apple's Competitive Position in Tech

Updated Category News Views 313

Understanding Apple's Competitive Landscape In today's dynamic business environment, a deep-dive analysis of top companies is essential for investors and industry insiders. This examination will focus on Apple (AAPL), alongside its chief rivals in the Technology Hardware, Storage & Peripherals sector. By analyzing crucial financial indicators, market positioning, and...

Continue Reading
Cegedim Shares Insights on Latest Liquidity Contract Performance

Updated Category News Views 135

Overview of Cegedim's Liquidity Contract Statement This article covers the latest updates on Cegedim’s liquidity contract performance, highlighting significant figures and trends that reflect the company's financial health. Cegedim has established a robust liquidity contract with Rothschild Martin Maurel, aimed at promoting transparency and liquidity in its shares. Key...

Continue Reading
Silexion Therapeutics Advances SIL204 for Pancreatic Cancer

Updated Category News Views 136

Silexion Therapeutics Moves Forward with SIL204 Silexion Therapeutics Corp. (NASDAQ: SLXN) is celebrating a significant milestone with the completion of crucial toxicology studies for its innovative RNA silencing therapy, SIL204. This groundbreaking therapy, designed to target mutated KRAS oncogenes, has shown no signs of systemic organ toxicity, reinforcing the...

Continue Reading
Emerson Partners with LifeSight for Enhanced Pension Solutions

Updated Category News Views 178

Emerson Partners with LifeSight for Pension Solutions LifeSight, WTW’s UK defined contribution (DC) master trust, has stepped into a significant role by becoming the full master trust provider for Emerson, the advanced electronics powerhouse. This partnership aims to cover all active, deferred, and drawdown members effectively, ensuring they are well-accommodated in...

Continue Reading
Howard Marks Joins Alliance for Decision Education Board

Updated Category News Views 227

Exciting News from the Alliance for Decision Education The Alliance for Decision Education is thrilled to announce an important addition to its Board of Directors. Howard Marks, a leader in investment management and a well-respected voice in decision-making, has agreed to join the board. As the co-chairman and co-founder of Oaktree Capital Management, Marks brings with...

Continue Reading